Rakuten Aspyrian scores $150 mln Series C
California, Japan and Germany-based Rakuten Aspyrian, a developer of precision-targeted cancer therapies, has raised $150 million in Series C financing. The lead investor was Hiroshi Mikitani, CEO of Rakuten Inc.
23 August 2018•1 min read
